Neuropsychopharmacology Reports

SJR Rank #10,568H-index: 27SJR: 0.561Best quartile: Q2Open AccessAPC: US$2,500Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

John Wiley & Sons Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Clinical PsychologyQ2
  • PharmacologyQ3
  • Pharmacology (medical)Q3
  • Psychiatry and Mental HealthQ3

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics · Psychology

Most published research topics

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionTryptophan and brain disordersAttention Deficit Hyperactivity DisorderSleep and related disordersBipolar Disorder and TreatmentSubstance Abuse Treatment and OutcomesElectroconvulsive Therapy StudiesNeuroscience and Neuropharmacology Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs065130195260

Documents per Year

202220250306090120

Detailed Information

ISSN

2574-173X

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.05

References per Document

39.68

Coverage

2018-2026

Scope

Neuropsychopharmacology Reports, the official publication of the Japanese Society of Neuropsychopharmacology, publishes articles on all aspects of neuropsychopharmacology and its related fields in the following categories: Review Articles, Original Articles, Micro Reports and Case Reports. Other categories may be occasionally set for invited articles.

Metrics from SCImago Journal Rank 2025. View on SCImago